Kolexia
Prevot Gregoire
Pneumologie
Hôpital Larrey Toulouse
Toulouse, France
232 Activités
0 Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Fibrose Fibrose pulmonaire Fibrose pulmonaire idiopathique Hypertension artérielle Hypertension pulmonaire Pneumopathies interstitielles Maladies pulmonaires Hypertension artérielle pulmonaire Sclérodermie systémique

Industries

Boehringer Ingelheim
18 collaboration(s)
Dernière en 2023
Sanofi
14 collaboration(s)
Dernière en 2023
RE-IMAGINE Health Agency
10 collaboration(s)
Dernière en 2021
Janssen
9 collaboration(s)
Dernière en 2023

Dernières activités

TETON-2: A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects With Idiopathic Pulmonary Fibrosis (TETON-2)
Essai Clinique (United Therapeutics)   14 mars 2024
EXAFIP2: Glucocorticoids Versus Placebo for the Treatment of Acute Exacerbation of Idiopathic Pulmonary Fibrosis: a Randomized Controlled Trial
Essai Clinique (Centre Hospitalier Saint Joseph Saint Luc)   14 décembre 2023
Webinaire PID chez l'adulte et l'enfant - 28 novembre 2023
Youtube @ RespiFIL   01 décembre 2023
HRCT imaging of pulmonary involvement in granulomatosis with polyangiitis and microscopic polyangiitis at disease onset and during follow-up.
Seminars in arthritis and rheumatism   04 novembre 2023
Infections in autoimmune pulmonary alveolar proteinosis: a large retrospective cohort.
Thorax   27 septembre 2023
Role of bronchoscopy for respiratory involvement in granulomatosis with polyangiitis and microscopic polyangiitis.
ERJ open research   11 septembre 2023
PROGRESSION: Pragmatic Management of Progressive Disease in Idiopathic Pulmonary Fibrosis: a Randomized Trial
Essai Clinique (Hospices Civils de Lyon)   03 août 2023
Risk factors of pulmonary relapse in microscopic polyangiitis and granulomatosis with polyangiitis.
Pulmonology   21 juillet 2023
Hypomorphic pathogenic variant in SFTPB leads to adult pulmonary fibrosis.
European journal of human genetics : EJHG   28 juin 2023
Rituximab and mycophenolate mofetil combination in patients with interstitial lung disease (EVER-ILD): a double-blind, randomised, placebo-controlled trial.
The European respiratory journal   08 juin 2023